インサイト
当社は航空衛星通信アンテナから体内埋め込みのバイオセンサー、脱炭素化の熱力学からAIを活用したバイオ工学まで、ディープテックの活用で現状を打破して変化を生み出しています。
最新の研究成果とインサイトをご紹介し、いま騒がれているイノベーションの先には何があるか、新しいテクノロジーがどのように重要なビジネス上の課題を解決しているかを解説します。
Unlocking the potential of IP-free gene editing to gain commercial advantage
CC’s transdisciplinary development team has created a way to democratise gene editing. This IP-free gene editing method avoids the timescales and costs involved with commercially licensing current CRISPR/Cas9 editing techniques ...
Engineering biology is driving the new bio-industrial revolution
Engineering biology, the fusion of biology and engineering principles, will be key to solving some of humanity’s most urgent challenges – from climate change and food security to healthcare and more ...
Primary care diagnostics are key to addressing antimicrobial resistance
Primary care is the hidden battlefield of antimicrobial resistance. It is here that more than 80% of all antibiotics are prescribed. Our experts are tackling the challenge of equipping primary care physicians with the right diagnostic and decision-making solutions ...
A potential gamechanger for the treatment of keratoconus
Deep tech consultants at Cambridge Consultants report on a potential gamechanger for the treatment of keratoconus, a challenging degenerative eye condition ...
From stealth mode to the shock of the new – how deep tech can boost company valuation
Why is deep tech important? What defines deep tech, and how to value deep tech companies? With stealth and surprise, deep tech can boost company valuation ...
Our people-centric design innovation is recognised on the global awards stage
An AstraZeneca concept collaboration is one of three projects by deep tech consultants at Cambridge Consultants to receive prestigious iF DESIGN AWARDS ...
Generative biology breakthrough from Capgemini – PharmaTimes
Capgemini announced on Monday that it had made a breakthrough in generative biology, also known as engineering or synthetic biology, at its deep tech powerhouse Cambridge Consultants. The news was been widely picked up, including by PharmaTimes ...
Capgemini reveals gen AI-driven breakthrough to accelerate the bioeconomy
Capgemini’s new patent-pending generative AI uses specialized large language models to accelerate the bioeconomy and biotechnology sector by drastically reducing the time and resources needed for research and development ...
